WednesdayJul 11, 2012 3:16 pm

Comstock Mining Inc. (LODE) Completes Crusher Construction, Looks to Commission Equipment, Expands Staff

Comstock Mining, the precious metal developer focused on their sizeable land package of contiguous properties in Nevada’s legendary Comstock Lode District, reported today that shortly after completion of the $2.4M heap leach facility (announced July 2) the company has also completed the new crusher facility’s construction. Comstock has already begun commissioning the necessary equipment for the new facility and anticipates rapidly accelerating testing/calibration over an approximately ten day period as the facility springs to life. Once the testing phase is complete, LODE will be stacking processed ore onto the heap and has already prepared the site for stock piling ore…

Continue Reading

WednesdayJul 11, 2012 12:05 pm

IsoRay, Inc. (ISR) Receives First International Orders for GliaSite Radiation Therapy System

IsoRay is a medical technology company and innovator in seed brachytherapy and medical radioisotope applications. The company, through its subsidiary IsoRay Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. This therapy is one of the most significant advances in internal radiation therapy in 20 years. The company today announced another step forward in the international adoption of its ground-breaking GliaSite radiation therapy system with the first order shipments to Germany. In addition to the orders, IsoRay reported that inquiries from Europe continue to grow. In addition to Germany, the company…

Continue Reading

WednesdayJul 11, 2012 8:16 am

Koss Corp. (KOSS) Enters Partnership with Mossy Oak® to Create Three New Headphone Products

Koss, a high fidelity stereophone manufacturer and inventor of the world’s first SP/3 Stereophone in 1958, based in Milwaukee, Wisconsin, announced a partnership with Mossy Oak. The partnership will allow for the combination of Mossy Oak’s award winning patterns and Koss Corporation’s headphones. Specifically, the Break-Up Infinity® and Break-Up® patterns will be applied hydrographically to three unique styles of headphones: a full-size stereophone, an on-ear stereophone, and two sets of earbud stereophones. The Koss KMO20G full size stereophone has been designed specifically to maximize comfort, durability, and performance. Extended frequency response was achieved through the implementation of dynamic elements throughout…

Continue Reading

WednesdayJul 11, 2012 8:13 am

Satcon Technology Corp. (SATC) Chosen for One of the Largest Solar PV Power Plants in California

Yesterday, Satcon Technology, a leader in providing utility-scale power conversion solutions for the renewable energy market, announced it has been selected to provide 51 MW of its Equinox Prism Platform solution and 1.5 MW of its next-generation Equinox inverter systems for a solar power plant in Southern California. The Equinox Prism Platform solution is a fully integrated multi-megawatt medium voltage (MV) building block. The installation will be interconnected to the San Diego Gas & Electric (SDGE) grid as a qualified facility for a large generator interconnection agreement (LGIA) under California Independent System Operator Corporation jurisdiction. It will be one of…

Continue Reading

TuesdayJul 10, 2012 3:30 pm

A.P. Pharma, Inc. (APPA) Receives 3 Patent Allowances for Lead Candidate APF530

Specialty pharmaceutical company A.P. Pharma today announced that the U.S. Patent and Trademark Office (USPTO) has allowed three new patents covering APF530, the company’s lead product candidate for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting (CINV). A.P. Pharma president and CEO John B. Whelan called the patents “instrumental” in augmenting the product’s overall patent life, which will extend through 2024. “A.P. Pharma continues to make advancements related to APF530 beyond clinical and regulatory development, and the allowance of these patents provides added strength to the APF530 patent estate and will help support the product’s longevity,” Whelan…

Continue Reading

TuesdayJul 10, 2012 1:35 pm

Gold Standard Ventures Corp. (GSV) Maps Main Mineralization Target at Flagship Property’s Key Site with CSAMT Geophysical Survey

Gold Standard Ventures has accrued a considerable acreage position through the company’s district-scale approach to accumulating mineralized gold acreage in Nevada’s prolific Carlin Trend and reported good news today on the North Bullion Fault Zone at their flagship Railroad Gold Project in Elko County, as the CSAMT (controlled-source audio-frequency magnetotelluric) geophysical survey has outlined the primary target area of high-grade gold mineralization discovered in recent drilling. The CSAMT was done by Zonge International out of Tucson and has delivered encouraging data that looked at some 42% of the over six mile-long North Bullion Fault Zone structural corridor (in 12 lateral…

Continue Reading

TuesdayJul 10, 2012 11:05 am

Serious about Trading? Then SeriousTraders is for You!

Our partner SeriousTraders knows that elite traders have to stay on top of the market at all times, and they stand behind them by continually searching for incredible trading opportunities. SeriousTraders is jam packed with informative market data and specialized articles; you won’t miss an opportunity to hone your trading edge. Even if you’re just looking to become a Serious Trader, but don’t know where to begin – look no further. SeriousTraders wants you to feel confident in the news and information they publish. That’s why SeriousTraders is constantly researching and updating their website to bring you the latest information.…

Continue Reading

TuesdayJul 10, 2012 8:36 am

CytRx Corp. (CYTR) Announces Allowance of US Patent Application

Yesterday, CytRx announced that the U.S. Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application with claims covering a pharmaceutical composition of the drug tamibarotene in capsule form. CytRx is currently conducting a Phase 2b global clinical trial with tamibarotene. CytRx is focused on research and development that specializes in oncology, and currently has three programs in their pipeline that are in clinical development for cancer indications: aldoxorubicin (formerly known as INNO-206), tamibarotene, and bafetinib. Furthermore, CytRX has initiated an international Phase 2b clinical trial as a treatment for soft tissue sarcomas, completed its…

Continue Reading

MondayJul 09, 2012 3:45 pm

Advanced Cell Technology, Inc. (ACTC) Receives Data and Safety Monitoring Board Authorization to Proceed with Patient Enrollment

Advanced Cell Technology, a leading player in the field of regenerative medicine, today announced it is now authorized to proceed with enrollment and treatment of additional patients in its clinical trial for dry age-related macular degeneration (dry AMD). The authorization, issued by the Data and Safety Monitoring Board (DSMB), allows ACT to continue patient screening and enrollment for the second cohort, who will be injected with 100,000 retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs), as compared with the 50,000-cell dose used in the first cohort. ACT says the DSMB clearance marks a key achievement for…

Continue Reading

MondayJul 09, 2012 11:43 am

Capstone Turbine Corp. (CPST) Receives 2MW Orders for Microturbines, Continued Signs of Expanding Market Position

Capstone Turbine, a top global cleantech manufacturer of low-emission microturbines, (and the first company to deliver a commercially viable microturbine to market) with over 6.5k units shipped worldwide, reported some 2MW worth of orders today from two sizeable domestic hydrocarbon producers, marking yet another set of customers in the oil and gas market to seize upon the benefits of the company’s robust, versatile microturbines for on-site prime power. Once again, trusted CPST distributor Horizon Power Systems can be thanked for diligently working to secure new deals, with the first order (a C1000 Power Package) being a follow-on order from a…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered